| Overview |
| bsm-54447r-100ul |
| MARK2 Recombinant Antibody |
| WB, FCM, IHC-P, IHC-F, IF(IHC-P) |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| Recombinant protein near the C-terminus of human MARK2. |
| Recombinant |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 2011 |
| Q7KZI7 |
| Cytoplasm, Cell membrane, Cytoskeleton |
| Serine/threonine-protein kinase MARK2; ELKL motif kinase 1; MAP/microtubule affinity-regulating kinase 2; EMK-1; Par-1b; Par1b; MARK2; EMK1 |
| MARK2 refers to MAP/microtubule affinity-regulating kinase 2 isoform a [Homo sapiens]. EMK (ELKL Motif Kinase) is a small family of ser/thr protein kinases involved in the control of cell polarity, microtubule.stability and cancer. Several cDNA clones have been isolated that encoded two isoforms of the human ser/thr protein kinase EMK1 called MARK2. These isoforms were characterized by the presence of a 162-bp alternative exon that gave rise to two forms, one containing the exon and the other one lacking it. Both forms were found to be coexpressed in a number of selected cell lines and tissue samples. Human MARK2 was shown to be encoded by a single mRNA ubiquitously expressed. This transcription variant includes the alternative exon in the coding region and therefore codes for a longer protein. Multiple splice variants exist for this protein. |
| Application Dilution |
| WB |
1:500-1000 |
| FCM |
FCM1:100-200 |
| IHC-P |
IHC-P1:50-200 |
| IHC-F |
IHC-F1:400-800 |
| IF(IHC-P) |
IFIHC-P1:100-500 |